文献速递贫血与红细胞疾病

铁过载的管理:输血依赖血红蛋白病的经验教训

Management of iron overload: lessons from transfusion-dependent hemoglobinopathies.
PubMed 文献 · Blood · 2025-01-01

本文综述了血红蛋白病及输血依赖性贫血患者铁毒性管理的经验,指出铁代谢认识、无创器官铁监测和有效铁螯合剂已显著降低铁过载发病率,但严重铁过载仍致显著病残和死亡,生存改善后长期贫血和铁暴露带来新并发症需在长期策略中考虑。

要点

  • 铁代谢知识、无创器官铁监测和有效铁螯合剂显著降低了铁过载发病率。
  • 严重铁过载在世界许多地区仍导致显著病残和死亡。
  • 生存改善后长期贫血和铁暴露带来新并发症,需在长期治疗策略中考虑。

核心结论

  • 当前对铁代谢的理解、无创器官铁监测和有效铁螯合剂已大幅降低铁过载发病率,但严重铁过载在世界许多地区仍导致显著病残和死亡。
  • 血红蛋白病的临床经验支持从动物研究学到的铁生物学,并识别出铁毒性生物学的共同概念,为多种人类疾病的铁毒性管理提供信息。
  • 生存的显著改善揭示了因更长期暴露于贫血和铁所致的新并发症,必须在长期治疗策略中加以考虑。

研究设计与样本

  • 本文为综述,讨论血红蛋白病和输血依赖性贫血患者铁毒性的管理以及铁生物学如何指导临床治疗。

主要发现

  • 在有效铁螯合剂出现之前,重型地中海贫血患者因铁诱导的心肌病和内分泌衰竭在第二个十年死亡。
  • 当前对铁代谢的理解、无创器官铁监测和有效铁螯合剂已大幅降低铁过载的发病率。
  • 生存的显著增加揭示了因更长期暴露于贫血和铁所致的新并发症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Before the advent of effective iron chelation, death from iron-induced cardiomyopathy and endocrine failure occurred in the second decade in patients with thalassemia major, and this experience has driven expectation of poor outcomes and caused anxiety in all disorders associated with iron loading to this day. To be clear, severe iron overload still causes significant morbidity and mortality in many parts of the world, but current understanding of iron metabolism, noninvasive monitoring of organ-specific iron loading in humans, and effective iron chelators have dramatically reduced morbidity of iron overload. Furthermore, clinical experience in hemoglobinopathies supports iron biology learned from animal studies and identifies common concepts in the biology of iron toxicity that inform the management of iron toxicity in several human disorders. The resultant significant increase in survival uncovers new complications due to much longer exposure to anemia and to iron, which must be considered in long-term therapeutic strategies. This review will discuss the management of iron toxicity in patients with hemoglobinopathies and transfusion-dependent anemias and how iron biology informs the clinical approach to treatment.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Coates TD. Management of iron overload: lessons from transfusion-dependent hemoglobinopathies. Blood. 2025. PMID: 39293029. doi:10.1182/blood.2023022502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。